Gene Therapy Weekly
Susan Hasty, Publisher
Table of Contents . . . April 1st, 1996
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
Conference Coverage (IBC Hepatitis) - DNA Vaccine for HBV Would Offer Many Advantages
Conference Coverage (CHI Vaccines) - Plant-Produced Vaccine Antigens: Safe, Cheap, and Stable
Conference Coverage (CHI Vaccines) - Virus-Like Particle Vaccines for VZV, HIV, Malaria, Hepatitis, More
Antisense Technology - ODN-S Inhibits Malaria Parasite Invasion of Red Cells
Breast Cancer (Genetics) - DNA Damage Linked to Risk of Cancer Spread
Cancer Gene Therapy - Gene Transfer Enables Bone Marrow Cells to Resist Trimetrexate Cytotoxicity
Cancer Gene Therapy - Transfer of TNF(alpha) Gene Restores Apoptotic Program
Genetics (HBV) - Genomes Associated with Fulminant Disease are Unique
Genetics (Testing) - Rapid DNA Probe Could Lead to Low-cost Tests for Diseases
Pathogenesis (HIV) - Multiprotein Complex IkappaB Inhibits HIV Replication
Placental Gene Therapy - Adenoviral-Mediated Placental Gene Transfer is Differentiation Dependent
Tissue Engineering - Progress Marked Toward Development of a Bioartifical Pancreas
Cancer Vaccines - "Clinical Responses in Patients Treated with a Melanoma Vaccine: Results from a Second Interim Analysis."
Cancer Vaccines - "Dendritic Cell-Based Cancer Vaccines In A Chimpanzee Model."
Cancer Vaccines - "Immune Response to CEA: Lessons from an Animal Model."
Drug Development (Antivirals) - "Antisense Oligonucleotides as Therapeutic Agents."
Immunotherapy - "Tumour Antigens and New Approaches to Cancer Therapy with Active Specific Immunotherapy (AS)."
Immunotherapy (Cancer) - "HLA Class II Expression in Melanoma: Implications for Immunotherapy."
Immunotherapy (Cancer) - "Tumor Infiltrating Lymphocytes from Human Ovarian Cancer Patients Recognize Autologous Tumor in an MHC-Class II Restricted Fashion."
Antisense Technology - "Cells Treated with TAP-2 Antisense Oligonucleotides Are Potent Antigen-Presenting Cells In Vitro and In Vivo."
Antisense Technology - "Reduction of Expression of the Multidrug Resistance Protein (MRP) in Human Tumor Cells by Antisense Phosphorothioate Oligonucleotides."
Cancer Gene Therapy - "High-Efficiency In Vivo Gene Transfer using Intraarterial Plasmid DNA Injection Following In Vivo Electroporation."
Cancer Gene Therapy - "Tissue-Targeted Antisense c-fos Retroviral Vector Inhibits Established Breast Cancer Xenografts in Nude Mice."
Cardiology - "Gene Therapy for Donor Hearts: Ex Vivo Liposome-Mediated Transfection."
Neurology - Experimental Paradigms and Clinical Perspectives."
Placental Gene Therapy - "Transduction of Human Trophoblast Cells by Recombinant Adenoviruses Is Differentiation Dependent."
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
